Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,593,690
+$337,938 QoQ
Shares Held
4,401
+23.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,406
of 3,140 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONECO ADVISORS, LLC holds $43,364,399 across 12 Drug Manufacturers - General names. AMGN ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,501 | $16,381,318 | |
| 2 | LLY |
ELI LILLY & Co
|
6,143 | $7,368,099 | |
| 3 | ABBV |
AbbVie Inc.
|
22,944 | $5,773,628 | |
| 4 | PFE |
Pfizer Inc
|
170,546 | $4,106,747 | |
| 5 | GSK |
GSK plc
|
60,767 | $3,185,406 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,894 | $2,427,879 | |
| 7 | AMGN |
Amgen Inc
This page
|
4,401 | $1,593,690 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
11,852 | $682,912 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,593,690 | 4,401 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,255,752 | 3,569 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,166,860 | 3,565 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,122,309 | 3,977 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $959,644 | 3,437 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $826,790 | 2,566 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $801,746 | 2,566 | Shares | Sole | 2024-07-19 | |
| 2023-03-31 | $446,270 | 1,846 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $218,516 | 832 | Shares | Sole | 2023-01-30 | |
| 2021-06-30 | $211,575 | 868 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||